GERN
GeronANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
GERN vs peer average
78/100
GERN vs. peer average (A vs. C)
Grade spread
B 3 · C 4 · D 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Similar-market-cap biopharma candidate from the packet; useful for small-cap biotech risk appetite, but direct operating overlap is not established.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GERN
Geron
ABUS
Arbutus Biopharma
Grade
A
C
Momentum
87
49
Value
41
41
Sentiment
65
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ABUS
GERN / ABUS
Grade Position
Above peers
GERN vs. peer average (A vs. C)
78/100
Momentum
87
GERNValue
41
GERNSentiment
65
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GERN
ABUS is the first peer returned for this comparison set.